Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
19
Frequently Asked Questions
What is Market Cap of Virax Biolabs Group Ltd - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Virax Biolabs Group Ltd - Ordinary Shares - Class A market cap is $2.69M.
What is the 52-week high for Virax Biolabs Group Ltd - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Virax Biolabs Group Ltd - Ordinary Shares - Class A 52 week high is $3.62 as of September 24, 2025.
What is the 52-week low for Virax Biolabs Group Ltd - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Virax Biolabs Group Ltd - Ordinary Shares - Class A 52 week low is $0.5202 as of September 24, 2025.
What is Virax Biolabs Group Ltd - Ordinary Shares - Class A stock price today?
Virax Biolabs Group Ltd - Ordinary Shares - Class A stock price today is $0.6468.
What was Virax Biolabs Group Ltd - Ordinary Shares - Class A stock price yesterday?
Virax Biolabs Group Ltd - Ordinary Shares - Class A stock price yesterday was $0.62.
What is the PE ratio of Virax Biolabs Group Ltd - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Virax Biolabs Group Ltd - Ordinary Shares - Class A’s P/E ratio is -0.38.
What is the Price-to-Book ratio of Virax Biolabs Group Ltd - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Virax Biolabs Group Ltd - Ordinary Shares - Class A P/B ratio is 0.4726.
What is the 50-day moving average of Virax Biolabs Group Ltd - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Virax Biolabs Group Ltd - Ordinary Shares - Class A 50-day moving average is $0.7602.
How many employess does Virax Biolabs Group Ltd - Ordinary Shares - Class A has?
Virax Biolabs Group Ltd - Ordinary Shares - Class A has 19 employees.
